Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wanjia Group HoldingsHKSE:00401 36 Days Payable is 53.10 as of Mar. 2026, which is 29% below its 10-year median of 74.55. GuruFocus rates HKSE:00401 with a GF Score™ of 36/100 and a GF Value™ of HK$0.06 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 117 Medical Distribution companies, Wanjia Group Holdings ranks worse than 82.05% on this metric.
The historical rank and industry rank for Wanjia Group Holdings's Days Payable or its related term are showing as below:
HKSE:00401'
s Days Payable Range Over the Past 10 Years
Min: 28.44 Med: 74.55 Max: 258.08
Current: 42.66
During the past 13 years, Wanjia Group Holdings's highest Days Payable was 258.08. The lowest was 28.44. And the median was 74.55.
HKSE:00401's Days Payable is ranked worse than 82.05% of 117
companies
in the Medical Distribution industry
Industry Median: 76.55
vs HKSE:00401: 42.66
Wanjia Group Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for Wanjia Group Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00401 vs MCK, COR, CAH: Days Payable Comparison
For the Medical Distribution subindustry, Wanjia Group Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wanjia Group Holdings Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Wanjia Group Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Wanjia Group Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Wanjia Group Holdings's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wanjia Group Holdings (HKSE:00401) has a Days Payable of 53.10 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Wanjia Group Holdings and its competitors. This is 29% below median its historical median of 74.55. Over the past decade, Wanjia Group Holdings' Days Payable has ranged from 28.44 to 258.08. According to the industry distribution chart, Wanjia Group Holdings ranks #96 out of 117 companies in the Medical Distribution industry, placing it in the top 82.1%.
Is Wanjia Group Holdings' Days Payable too high?
Wanjia Group Holdings' current Days Payable of 53.10 is 29% below median its 10-year median of 74.55. Over the past 10 years, this metric has ranged from a low of 28.44 to a high of 258.08. The Medical Distribution industry median Days Payable is 76.55. Wanjia Group Holdings' value of 53.10 is 30.6% below this industry median. Based on the distribution chart, Wanjia Group Holdings ranks #96 out of 117 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Wanjia Group Holdings has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wanjia Group Holdings' Days Payable compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Wanjia Group Holdings ranks #96 out of 117 companies for Days Payable. This places Wanjia Group Holdings in the lower half of its industry. The industry median Days Payable is 76.55. Wanjia Group Holdings' value of 53.10 is 30.6% below this benchmark. Historically, Wanjia Group Holdings' own Days Payable has ranged from 28.44 to 258.08 over the past decade. While the company's 10-year median is 74.55 vs. the industry median of 76.55, Wanjia Group Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 76.55, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wanjia Group Holdings's current Days Payable of 53.10 is 30.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Wanjia Group Holdings and its competitors. For the Medical Distribution industry, the median Days Payable is 76.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wanjia Group Holdings's current Days Payable is 53.10, which is 29% below median its own 10-year median of 74.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wanjia Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Wanjia Group Holdings (HKSE:00401) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.06, compared to a current price of HK$0.13 — trading 116.7% above its estimated fair value. The current Days Payable is 53.10, which is 29% below median its 10-year median of 74.55 and 30.6% below the Medical Distribution industry median of 76.55. Wanjia Group Holdings' overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Wanjia Group Holdings (HKSE:00401), the current Days Payable is 53.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wanjia Group Holdings (HKSE:00401) Overvalued in 2026?
Based on GuruFocus' analysis, Wanjia Group Holdings stock appears to be overvalued.
The current stock price of HK$0.13 is trading 116.7% above its estimated GF Value™ of HK$0.06.
GuruFocus considers Wanjia Group Holdings to be Significantly Overvalued.
Key valuation signals for HKSE:00401:
Days Payable: 53.10 (29% below median its 10-year median of 74.55)
GF Value™: HK$0.06 vs. price of HK$0.13 (116.7% above fair value)
Industry Position: 30.6% below the Medical Distribution median (#96 of 117)
No single metric tells the full story. See the HKSE:00401 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wanjia Group Holdings Ltd is an investment holding company. Along with its subsidiaries, the company operates in principal activities of Pharmaceutical wholesale and distribution business, and Hemodialysis treatment and consultancy service business. The company generates key revenue from the Hemodialysis treatment and consultancy service business. Geographically, company operates in Hong Kong and China, having majority revenue generation from Mainland China.
36GF Score
Get the complete analysis for HKSE:00401
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00401 has been successfully added to your 
